Shares of Arena Pharmaceuticals rose 2.73% to $74.19 at 11:40 EST on Friday, after four consecutive sessions in a row of gains. The Nasdaq Stock Market is dropping 0.26% to $12,731.30, after four successive sessions in a row of gains. This seems, as yet, a somewhat negative trend exchanging session today.

Arena Pharmaceuticals’s last close was $72.22, 21.57% below its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the current quarter and 155.7% for the next. The company’s growth estimates for the current quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value

Arena Pharmaceuticals’s stock is valued at $74.19 at 11:40 EST, way below its 52-week high of $90.19 and way higher than its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is higher than its 50-day moving average of $71.46 and higher than its 200-day moving average of $69.42.


Please enter your comment!
Please enter your name here